The 8-hour Buprenorphine Training
PCSS is a program funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) created in response to the opioid overdose epidemic to train primary care providers in the evidence-based prevention and treatment of opioid use disorders (OUD) and treatment of chronic pain. PCSS is made up of a coalition, led by American Academy of Addiction Psychiatry (AAAP), of major health organizations, all dedicated to addressing this healthcare crisis. Through a variety of trainings and a clinical mentoring program, PCSS’s mission is to increase healthcare providers’ knowledge and skills in the prevention, identification, and treatment of substance use disorders with a focus on opioid use disorders.
PCSS is made up of a coalition of 23 leading national organizations representing healthcare providers and other key stakeholders who are working on the front lines of the opioid crisis. View our Partner Organizations: Partner Organizations
1st Half of the Course
A face-to-face or live webcast training for a 4.25-hour session. The training focuses on specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment.
2nd Half of the Course
3.75 hours of on-your-own computer-based training on substance abuse treatment, opioids, and the use of buprenorphine in the treatment of opioid use disorders from office-based practices. An examination must be successfully completed to at the end of this session.
Removal of DATA Waiver (X-Waiver) Requirement
PCSS and the AOAAM believes strongly in the educational value of this buprenorphine training and encourages you to proceed.
Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver applications).
All practitioners who have a current DEA registration that includes Schedule III authority, may now prescribe buprenorphine for Opioid Use Disorder in their practice if permitted by applicable state law and SAMHSA encourages them to do so. SAMHSA and DEA are actively working on implementation of a separate provision of the Omnibus related to training requirements for DEA registration that becomes effective in June 2023. For further guidance and updates please continue to check:
Continuing Medical Education
Half and Half Training - Live Webcasts and Face-to-Face
This program has been approved for 4.25 AOA Category 1-A CME credits
providing all requirements have been met. This program has also been approved
for 4.25 AAFP Prescribed Credit hours, by the American Academy of Family
Physicians. Physicians should claim only the credit commensurate with the
extent of their participation in the activity. AAFP Prescribed credit is
accepted by the American Medical Association as equivalent to AMA PRA
Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying
for the AMA PRA, Prescribed credit earned must be reported as Prescribed
credit, not as Category 1. Participants are required to attend the entire
4.25-hour session and participate in the polling questions in order to be eligible for CME credit. Please
verify with the AOAAM for all CME details on the live trainings as the
CME component may differ for each individual training date and location
depending on the sponsoring organization and faculty.
8-Hour Training - Face-to-Face Format
This training has been reviewed and is acceptable for up to 8.00 Prescribed
credit(s) by the American Academy of Family Physicians. Physicians should claim
only the credit commensurate with the extent of their participation in the
activity. AAFP Prescribed credit is accepted by the American Medical
Association as equivalent to AMA PRA Category 1 Credit™ toward the
AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit
earned must be reported as Prescribed credit, not as Category 1. The
American Osteopathic Academy of Addiction Medicine (AOAAM) is accredited by the
American Osteopathic Association to provide osteopathic continuing medical
education for physicians. The AOAAM anticipates this program being approved for
a maximum of 8.0 AOA Category 1-A credits and will report CME credits
commensurate with the extent of the physician’s participation in this
activity. Please check with the AOAAM for all CME details on the 8-Hour
Face-to-Face training as this component may differ for each individual training
date and location depending on the sponsoring organization and faculty.
Program Goals and Objectives
PCSS’ Mission is to promote evidence-based resources and clinical practices.
1.) Maintain and expand a comprehensive electronic repository of training materials and educational resources to support evidence-based treatment of opioid use disorder.
Training is designed to increase the knowledge base and clinical proficiency of prescribers and providers from diverse multi-disciplinary healthcare backgrounds. An on-line curriculum includes:
- Patient selection and matching with treatment setting (residential, outpatient program, office-based) and specific medications (methadone, buprenorphine, or naltrexone)
- Practical guidelines for detoxification (both outpatient and inpatient)
- Implementing antagonist-based treatment, managing long-term maintenance on medications
- Transitioning from agonist- to antagonist-based treatment
- Managing substance use and co-occurring psychiatric disorders
- Treatment of individuals with co-occurring medical problems and chronic pain
- Treatment in specialized populations such as adolescents, elderly, pregnant women, and those involved in veterans and criminal justice healthcare systems (for detailed description of the training curriculum, see below).
The content of educational resources is overseen by a panel of experienced clinicians, researchers, and educators forming a Clinical Expert Panel.
2.) Expand existing clinical mentoring program to provide guidance to prescribers and key health professionals on prevention, identification, and treatment of opioid use disorder.
3.) Expand MOUD training for physicians, nurse practitioners, and physician assistants.
- The program provides clinical mentors and matches them with clinicians. Communications between mentors and clinicians is primarily via phone and Internet (email, video). A discussion forum, moderated by an addiction expert, allows healthcare professionals to post questions and to encourage communication among a wide range of providers.
- All PCSS trainings are FREE and available to physicians, physicians’ assistants, nurse practitioners and other medical professionals.·
For More Information and FREE training and educational resources on MOUD visit pcssNOW.org.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Non-members interested in CME must create a profile with AOAAM. Subscribe now or Join Us to receive the full benefits of membership.